Ian Kennedy

Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases

Gabriel N. Hortobágyi, Richard L. Theriault, Lester Porter et al. · New England Journal of Medicine · 1996 · 1K citations

Medicine, Cancer Biology, Oncology +14

Pamidronate Reduces Skeletal Morbidity in Women With Advanced Breast Cancer and Lytic Bone Lesions: A Randomized, Placebo-Controlled Trial

Richard L. Theriault, Allan Lipton, Gabriel N. Hortobágyi et al. · Journal of Clinical Oncology · 1999 · 606 citations

Medicine, Oncology, Breast Oncology +16

Docetaxel and Doxorubicin Compared With Doxorubicin and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer: Results of a Randomized, Multicenter, Phase III Trial

Jean‐Marc Nabholtz, Carla I. Falkson, J. Szántó et al. · Journal of Clinical Oncology · 2003 · 384 citations

Medicine, Oncology, Pharmacology +12

Initial Paclitaxel Improves Outcome Compared With CMFP Combination Chemotherapy as Front-Line Therapy in Untreated Metastatic Breast Cancer

James F. Bishop, Joanna Dewar, Guy C. Toner et al. · Journal of Clinical Oncology · 1999 · 211 citations

Medicine, Oncology, Pharmacology +10

Characterization of the family of dimers associated with Fc receptors (Fc epsilon RI and Fc gamma RIII)

Odile Letourneur, Ian Kennedy, A.T. Brini et al. · The Journal of Immunology · 1991 · 114 citations · Full text

Life Sciences, Immunology, Molecular Biology +15